Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
about
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsHBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma.Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma.Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?Tumor repressor gene chondroadherin oppose migration and proliferation in hepatocellular carcinoma and predicts a good survival.Gallic acid as a selective anticancer agent that induces apoptosis in SMMC-7721 human hepatocellular carcinoma cells.The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147.LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma.miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability.Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway.Clinical and Diagnostic Significance of Homer1 in hepatitis B virus-induced Hepatocellular Carcinoma.Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling
P2860
Q37706763-EC17FC21-9C2B-4729-8596-C1760BA30F1EQ40216193-AAC6C648-FBB1-4440-B069-593A01CB363EQ40684744-2E53661E-7A62-4CE9-B31B-9293846980CCQ41369277-5BFF4E5C-601D-421C-852F-B1892BC7B7E5Q41694075-43993667-B52F-48EF-96EF-8FC596FDC35BQ42016485-9E948323-FA2A-4556-AE36-093E99CB9A60Q42324249-DF00B332-096E-444F-A6DF-A3D35C140386Q47253673-A9FDE812-B125-4F21-8C24-11CFE2280DAAQ47300446-DCFC8272-D21B-4152-B8F1-478A46ED3A5EQ49547857-89FC1B95-F265-41DB-9E8D-502786CE6D4CQ49638741-C71C7BE0-EA1C-4C73-BDED-3F729FF26EB5Q52647682-D3499CA7-0CE5-4BF7-BDAF-572AFB7BBE20Q53531177-09B27089-1A59-47D0-9341-9C4B9424EB4FQ57473743-72F5CA10-568E-4B53-A493-A3731BEBA3A0
P2860
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@ast
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@en
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@nl
type
label
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@ast
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@en
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@nl
prefLabel
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@ast
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@en
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@nl
P2860
P1476
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
@en
P2093
P2860
P304
P356
10.3748/WJG.V20.I30.10249
P407
P577
2014-08-14T00:00:00Z